$1.62
-0.04-2.41%
Last update: Nov 4, 4:29 PM
Inovio Pharmaceuticals Inc (INO) Stock Price, Quote, News & History
INONASDAQ
Inovio stock surges after FDA accelerated approval of Voceryq, an immunotherapy reducing surgeries for adults with recurrent respiratory papillomatosis.
You can purchase shares of Inovio Pharmaceuticals (NASDAQ:INO) through any online brokerage.
Other companies in Inovio Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Inovio Pharmaceuticals has a consensus price target of $14.00.
The stock price for Inovio Pharmaceuticals (NASDAQ: INO) is $1.62 last updated November 4, 2026 at 4:29 PM EST.
There are no upcoming dividends for Inovio Pharmaceuticals.
Inovio Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Inovio Pharmaceuticals.
Inovio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases....
